Bergen, Norway 8 November 2021
Please find enclosed the presentation held by Lifecare AS' CSO Prof. AndreasPfützner at the 20th annual Diabetes Tech Meeting 6 November 2021. Topic of thepresentation was the EU funded project Forget Diabetes: a novel automatedinsulin delivery system, of which Lifecare in cooperation with 6 academicpartners cross Europe aim to develop an artificial pancreas where the sensingsystem is based on the Sencell technology.
This is LifecareLifecare is a Bergen-based technology company developing a miniaturizedimplantable long-term sensor for correct and continuous monitoring of bloodsugar in people with diabetes. The Company's patented technology also has thepotential for use in various biomarkers. Lifecare AS is listed on EuronextGrowth (LIFE).
Further information Joacim Holter, CEO, Lifecare AS, firstname.lastname@example.org,+47 40 05 90 40
This stock exchange announcement was published by Kine Hereid, InvestorRelations at Lifecare AS, on 08.11.2021 at 08.30 CET.